The therapeutic efficacy of the AZT and IFN combination in ATL presumably reflects the inhibition of RT-related functions.HTLV-1-RT activity from short-term cultured PBMCs may represent a predictive correlate of clinical response to AZT/IFN in ATL patients.
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α
Balestrieri, Emanuela;Frezza, Caterina;Marino-Merlo, Francesca;Mastino, Antonio
Penultimo
;
2017-01-01
Abstract
The therapeutic efficacy of the AZT and IFN combination in ATL presumably reflects the inhibition of RT-related functions.HTLV-1-RT activity from short-term cultured PBMCs may represent a predictive correlate of clinical response to AZT/IFN in ATL patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2017 02 BloodAdvances_ MacchiATL.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
968.88 kB
Formato
Adobe PDF
|
968.88 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
